ES2127294T3 - Vacunas del virus de la inmunodeficiencia anti-felino (fiv). - Google Patents

Vacunas del virus de la inmunodeficiencia anti-felino (fiv).

Info

Publication number
ES2127294T3
ES2127294T3 ES93920971T ES93920971T ES2127294T3 ES 2127294 T3 ES2127294 T3 ES 2127294T3 ES 93920971 T ES93920971 T ES 93920971T ES 93920971 T ES93920971 T ES 93920971T ES 2127294 T3 ES2127294 T3 ES 2127294T3
Authority
ES
Spain
Prior art keywords
ivf
vaccines
feline immunodeficiency
immunodeficiency viruses
combat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93920971T
Other languages
English (en)
Inventor
Michael James Francis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of ES2127294T3 publication Critical patent/ES2127294T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL PRESENTE INVENTO PROPORCIONA UN POLIPEPTIDO SINTETICO QUE COMPRENDE TODA O PARTE DE UNA SECUENCIA AMINOACIDA SELECCIONADA DE (I), O UN FRAGMENTO ANTIGENICO, UNA VARIANTE FUNCIONALMENTE EQUIVALENTE O SU SAL FARMACEUTICAMENTE ACEPTABLE. TAMBIEN SE FACILITAN MOLECULAS DE ACIDO NUCLEICO QUE CODIFICAN TALES POLIPEPTIDOS, METODOS DE PREPARACION, COMPOSICIONES DE VACUNAS QUE LAS CONTIENEN Y SU EMPLEO, TANTO PARA COMBATIR EL FIV COMO PARA DIAGNOSTICAR SU INFECCION.
ES93920971T 1992-09-21 1993-09-20 Vacunas del virus de la inmunodeficiencia anti-felino (fiv). Expired - Lifetime ES2127294T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219936A GB9219936D0 (en) 1992-09-21 1992-09-21 Vaccines

Publications (1)

Publication Number Publication Date
ES2127294T3 true ES2127294T3 (es) 1999-04-16

Family

ID=10722245

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93920971T Expired - Lifetime ES2127294T3 (es) 1992-09-21 1993-09-20 Vacunas del virus de la inmunodeficiencia anti-felino (fiv).

Country Status (11)

Country Link
EP (1) EP0661999B1 (es)
JP (1) JP3604384B2 (es)
AT (1) ATE175119T1 (es)
AU (1) AU4826493A (es)
DE (1) DE69322872T2 (es)
DK (1) DK0661999T3 (es)
ES (1) ES2127294T3 (es)
GB (1) GB9219936D0 (es)
GR (1) GR3029264T3 (es)
WO (1) WO1994006471A1 (es)
ZA (1) ZA936970B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2267101T3 (es) * 1994-04-29 2007-03-01 PHARMACIA & UPJOHN COMPANY LLC Vacuna contra virus de inmunodeficiencia felina.
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
CA2230029C (en) * 1995-08-25 2012-03-27 University Of Florida Multi-subtype fiv vaccines
FR2769916B1 (fr) 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
GB9827077D0 (en) 1998-12-09 1999-02-03 Expro North Sea Ltd Improvements in or relating to well fluid sampling
DE50010240D1 (de) * 1999-07-08 2005-06-09 Mologen Forschungs Entwicklung Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze
FR2828687B1 (fr) * 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
FR2828686B1 (fr) * 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
JP2007505320A (ja) 2003-09-11 2007-03-08 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
EP1709447B1 (en) 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Method for detecting feline immunodeficiency virus
AU2005215629B2 (en) 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4866848B2 (ja) 2004-06-30 2012-02-01 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルス（ｆｉｖ）のｅｎｖタンパク質のｖ３領域に由来するペプチドの使用を含むｆｉｖを検出するための方法および装置
EP1761555A1 (en) 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
DE69223250T3 (de) * 1991-06-14 2008-02-28 Idexx Laboratories, Inc. Detektion des immunschwäche-virus aus felis
WO1993001304A1 (en) * 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins

Also Published As

Publication number Publication date
JPH08504090A (ja) 1996-05-07
JP3604384B2 (ja) 2004-12-22
GB9219936D0 (en) 1992-11-04
AU4826493A (en) 1994-04-12
DK0661999T3 (da) 1999-08-30
DE69322872D1 (de) 1999-02-11
EP0661999B1 (en) 1998-12-30
ZA936970B (en) 1994-08-29
ATE175119T1 (de) 1999-01-15
DE69322872T2 (de) 1999-05-27
GR3029264T3 (en) 1999-05-28
EP0661999A1 (en) 1995-07-12
WO1994006471A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
ES2029171A6 (es) Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh)
ES2006925A6 (es) Procedimiento para la preparacion de vectores de expresion.
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
DK11789A (da) Rekombinante vaccinia-vira
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
RU94042722A (ru) Химерный белок, ген, клетка, вектор, способ получения химерного белка, вакцина
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
DE68925660D1 (de) Peptidfragmente von HIV
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
ES2061603T3 (es) Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.
ATE154244T1 (de) Induzierung eines schutzes gegen virale infektionen
ES2077017T3 (es) Vacuna contra el virus de la bronquitis infecciosa.
ES2085163T3 (es) Vacunas contra los parasitos metazoos.
ATE208421T1 (de) Stimulierung der immunantwort durch virales protein
PT99791A (pt) Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem
DK204588A (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider
ES2055610T3 (es) Vacuna contra hrsv.
PL442478A1 (pl) Kompozycja szczepionki do zastosowania w profilaktyce chorób zakaźnych
MX169441B (es) Peptidos capaces de ser reconocidos por anticuerpos inducidos contra el retro-virus de inmunodeficiencia humana (hiv-virus) sus aplicaciones para diagnostico de infecciones causadas por alguno de estos virus y en su caso, para vacunas contra sida
Duff PSITTACOSIS GROUP VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661999

Country of ref document: ES